Lupus nephritis: The value of biochemical and immunological monitoring of disease activity

Renal Failure

Volumn 18, Issue 5, 1996, Pages 755-763

  Vangelista, Alba ^a   Stipo, Lucia ^a   Canova, Cristina ^a   Frascà, Giovanni Maria ^a   Iannelli, Sandra ^a   Nanni Costa, Alessandro ^a   Bonomini, Vittorio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; HLA ANTIGEN CLASS 1; INTERLEUKIN 1; INTERLEUKIN 2;

ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNITY; CONFERENCE PAPER; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; IMMUNOLOGICAL MONITORING; IMMUNOPATHOGENESIS; LUPUS ERYTHEMATOSUS NEPHRITIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0029914154     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229609047704     Document Type: Conference Paper

References (35)

1. Hill GS: Systemic lupus erythematosus and mixed connective-tissue disease. In Heptinstall RH (ed), Pathology of the Kidney. Boston, Little, Brown, 1992, pp 871-950.
2. Esdaile JM, Abrahamowicz A, MacKenzie T, et al: Time-dependence of long-term prediction in lupus nephritis. Arthritis Rheum 37:359-368, 1994.
3. Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982.
4. Font J, Torras A, Cervera R, et al: Silent renal disease in systemic lupus erythematosus. Clin Nephrol 27:283-288, 1987.
5. Golbus J, McCune WJ: Lupus nephritis: classification, prognosis, immunopathogenesis, and treatment. Rheum Dis Clin North Am 20:213-242, 1994.
6. Morel-Maroger L, Mery JPH, Droz D, et al: The course of lupus nephritis: contributions of serial biopsies. In Hamburger J, Crosnier J, Maxwell MH (eds) Advances in Nephrology. Chicago, Year Book Medical Publishers, 1976, pp 79-118.
7. Adu D, Cameron JS: Lupus nephritis. Clin Rheum Dis 8:153-182, 1982.
8. Mahajan SK, Ordonez NG, Spargo BH, Katz AI. Changing histopathology patterns in lupus nephropathy. Clin Nephrol 10:1-8, 1978.
9. Glassock RJ, Goldstein DA. Finander P, et al: Glomerulonephritis in systemic lupus erythematosus. Am J Nephrol 1:53-67, 1981.
10. Elkon KB. Autoantibodies in SLE. In Klippel JH, Dieppe PA (eds) Rheumatology. St. Louis, Mosby, 1994, pp (6) 4.1-4.10.
11. Isenberg DA, Shoenfeld Y, Madadio MP, et al: Measurement of anti-DNA antibody idiotypes to monitor the course of systemic lupus erythematosus. Lancet 2:417-421, 1984.
12. Cronin ME, Leiar DW, Jaronski S, Lightfoot RW: Simultaneous use of multiple serologic tests to assess clinical activity in systemic lupus erythematosus. Clin Immunol Immunopathol 51:99-105, 1989.
13. Fournié GJ: Circulating DNA and lupus nephritis. Kidney Int 33:487-491, 1988.
14. Ter Borg EJ, Horst G, Hummel EJ, et al: Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. Arthritis Rheum 33:634-643, 1990.
15. Walz LeBlanc BAE, Gladman DD, Urowitz MB: Serologically active clinically quiescent lupus erythematosus: Predictors of clinical flares. J Rheumatol 21:2239-2241, 1994.
16. Edberg JC, Salmon JE, Forges AJ, et al: Systemic lupus erythematosus: Immunopathology. In Klippel JH, Dieppe PA (eds), Rheumatology. St. Louis, Mosby, 1994, pp (6)3.1-3.12.
17. Schur PH, Marcus-Bagley D, Awdeh Z, et al: The effect of ethnicity on major histocompatibility complex complement allotypes and extended haplotypes in patients with systemic lupus erythematosus. Arthritis Rheum 33:985-992, 1990.
18. Dunckley J, Gatenby PA, Awkins B, et al: Deficiency of C4A is a genetic determinant of systemic lupus erythematosus in three ethnic groups. J Immunogenet 14.209-218, 1987.
19. Porcel JM, Ordi J, Castro-Salomo A, et al: The value of complement activation products in the assessment of systemic lupus erythematosus flares Clin Immunol Immunopathol 74.283-288, 1995.
20. West CD: Relative value of serum C3 and C4 levels in predicting relapse in systemic lupus erythematosus. Am J Kidney Dis 18:686-688, 1992.
21. Austin HA, Boumpas DT, Waughan EM, Balow JE: Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 45:544-550, 1994.
22. Kammer GM, Stein RL: T lymphocyte immune dysfunction in systemic lupus erythematosus. J Lab Clin Med 115:273-282, 1990.
23. Tsokos GC: An overview of cellular immune function in systemic lupus erythematosus. In Lahita RG (ed). Systemic Lupus Erythematosus New York, Churchill-Livingstone, 1992, pp 15-50.
24. Balow JE, Tsokos GC: T and B lymphocyte function in patients with lupus nephritis: correlation with renal pathology. Clin Nephrol 21:93-97, 1984.
25. Crow MK, Friedman SM: Systemic lupus erythematosus. Cellular immunology. In Klippel JH, Dieppe PA (eds). Rheumatology St. Louis, Mosby, 1994, pp (6)5.1-5.10.
26. Al-Janadi M, Raziuddin S: B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus. J Rheumatol 20:1885-1891, 1993.
27. Linker-Israeli M, Hyun S, Ozeri-Chen T, et al: Elevated in vivo and in vitro secretion of CDS-α molecules in patients with systemic lupus erythematosus. J Immunol 152:3158-3167, 1994.
28. Osman C, Swaak AJG: Lymphocytotoxic antibodies in SLE: a review of the literature. Clin Rheumatol 13:21-27, 1994.
29. Wuthnch RP, Snyder TL: Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis. Kidney Int 42:903-914, 1992.
30. Sfikakis PP, Charalambopoulos D, Vayiopoulos G, et al: Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus. Clin Exp Rheumatol 12:5-9, 1994.
31. Belmont HM, Buyon J. Giorno R, Abramson S: Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. Arthritis Rheum 37:376-383, 1994.
32. Spronk PE, Bootsma H, Huitema MG, et al: Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long-term prospective study. Clin Exp Immunol 97:439-444, 1994.
33. Janssen BA, Luqmani RA, Gordon C, et al: Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis. Br J Rheumatol 33:1112-1116, 1994.
34. Nanni-Costa A, Brando B, Iannelli S, et al: Anti-HLA antibody detection in renal transplant recipients by ELISA screening method. 7th Congress ESOT, Vienna 1995, Abstract Book, p 161.
35. National Institute of Health Transplantation and Immunology Branch Staff: NIH lymphocyte microcytotoxicity technique. In Ray JG Jr (ed) Manual of Tissue Typing Techniques. NIH Publ 80-545. U.S. Department of Health, Education and Welfare, 1979, p 39.